ANN ARBOR STAGE II MARGINAL ZONE LYMPHOMA

Clinical trials for ANN ARBOR STAGE II MARGINAL ZONE LYMPHOMA explained in plain language.

Never miss a new study

Get alerted when new ANN ARBOR STAGE II MARGINAL ZONE LYMPHOMA trials appear

Sign up with your email to follow new studies for ANN ARBOR STAGE II MARGINAL ZONE LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet finished but already full! 1

Gentler cancer treatment trial seeks to control Slow-Growing lymphoma

Disease control Recruiting now

This study is testing whether a lower dose of the drug mosunetuzumab can effectively treat slow-growing B-cell lymphomas while potentially reducing side effects. The trial will enroll 20 adults with early-stage, low-tumor-burden lymphoma who haven't had prior treatment. Researche…

Matched conditions: ANN ARBOR STAGE II MARGINAL ZONE LYMPHOMA

Phase: PHASE2 • Sponsor: University of Washington • Aim: Disease control

Last updated Mar 27, 2026 12:39 UTC

ANN ARBOR STAGE II MARGINAL ZONE LYMPHOMA

Get alerted when new ANN ARBOR STAGE II MARGINAL ZONE LYMPHOMA trials appear

Gentler cancer treatment trial seeks to control Slow-Growing lymphoma